Table 1.
Histopathological feature | Agreement (%) | 95% CI (%) | GAC2 | 95% CI | KA | 95% CI |
---|---|---|---|---|---|---|
Grade (1, 2 or 3) | 76.4 | 75.27–77.52 | 0.52 | 0.50–0.55 | 0.34 | 0.30–0.39 |
Grade (1 versus 2 + 3) | 83.5 | 81.33–85.68 | 0.78 | 0.74–0.82 | 0.35 | 0.28–0.42 |
Grade (1 + 2 versus 3) | 69.3 | 66.94–71.63 | 0.43 | 0.38–0.49 | 0.34 | 0.29–0.38 |
Grade (low versus high) | 72.8 | 70.54–75.12 | 0.52 | 0.47–0.57 | 0.38 | 0.32–0.44 |
Dominant growth pattern | 84.8 | 82.58–86.97 | 0.78 | 0.75–0.82 | 0.44 | 0.37–0.51 |
Calcifications | 81.1 | 78.81–83.40 | 0.70 | 0.65–0.75 | 0.49 | 0.43–0.54 |
Necrosis | 81.4 | 79.12–83.64 | 0.70 | 0.66–0.75 | 0.47 | 0.41–0.53 |
Mitotic activity | 78.5 | 76.12–80.97 | 0.70 | 0.65–0.74 | 0.24 | 0.19–0.29 |
Periductal fibrosis (absent, subtle or prominent presence) | 70.9 | 69.71–72.13 | 0.37 | 0.34–0.39 | 0.25 | 0.22–0.29 |
Periductal fibrosis (present versus absent) | 71.2 | 68.82–73.48 | 0.53 | 0.48–0.58 | 0.23 | 0.18–0.28 |
Type of periductal fibrosis (if present) | 70.5 | 67.57–73.37 | 0.50 | 0.44–0.57 | 0.26 | 0.21–0.31 |
Lymphocytic infiltrate (absent, subtle or prominent presence) | 77.1 | 75.82–78.36 | 0.50 | 0.47–0.53 | 0.42 | 0.38–0.47 |
Lymphocytic infiltrate (present versus absent) | 73.0 | 70.51–75.40 | 0.51 | 0.45–0.56 | 0.38 | 0.33–0.43 |
GAC2 Gwet’s AC2, KA Krippendorff’s alpha, weighted analysis was performed for ordinal features with more than 2 categories using linear weights (grade 1–3, periductal fibrosis, and lymphocytic infiltrate), CI confidence interval